We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Shonali Midha MD

Shonali Midha MD

Physician at Dana-Farber Cancer Institute, Instructor in Medicine, Harvard Medical School, Boston, MA

Shonali Midha, MD is a Physician at Dana-Farber Cancer Institute and an Instructor in Medicine at HMS focused on the treatment of Multiple Myeloma and Plasma Cell Disorders. She completed her internal medicine residency training at the University of South Florida in Tampa, FL, where she completed a Chief Residency year and her hematology/oncology fellowship at Moffitt Cancer Center, Tampa, FL where she also served as Chief Fellow. Her academic focus is on the diagnosis, management and treatment of plasma cell disorders, specifically within the field of novel cellular therapies and immunotherapy for the treatment of myeloma. Specifically, her clinical and research interests include further understanding the biology of and identifying targeted therapeutics for high-risk and ultra high-risk disease as well as the role of Myc dysregulation in multiple myeloma.